Dr. Christine Desbiens, a surgical oncologist at the CHU de Québec-Université Laval and member of our Executive Scientific Committee, participated in the oncology researchers’ tour that took place in France during the week of October 11th.
Organized in partnership with Oncopole and the Consulat général de France à Québec, the purpose of this tour was, among other things, to discuss oncology practices and to facilitate the provision of resources for joint research.
Dr. Desbiens presented her activities at the Centre des maladies du sein Deschênes-Fabia of the CHU de Québec-Université Laval, but she also took the opportunity to bring to the fore the innovative approach of our research consortium.
She demonstrated the benefits of bringing together different hospitals by joining forces in the field of clinical research in breast cancer, particularly in terms of potential for patient recruitment. This common will is in fact very enticing for promoters of clinical research and results in increasing the offer of trials to patients with breast cancer.
Among the activities organized as part of this tour, Quebec researchers were able to visit cutting-edge cancer centers including the Institut Gustave Roussy in Villejuif, the CLARA (Cancéropôle Lyon Auvergne-Rhône-Alpes) in Lyon and the Institut Curie in Paris (see photo).
From left to right: Dr. François-Michel Boisvert, Director of the Institut de Recherche sur le Cancer de l’Université de Sherbrooke; Dr. Denis Claude Roy, Scientific Director of the Institut universitaire en hémato-oncologie et en thérapie cellulaire at l’Hôpital Maisonneuve-Rosemont; Dr. Hélène Decaluwe, Clinical Researcher and Deputy Head of the immune diseases and cancer research axis at the Centre de recherche CHU Sainte-Justine; Xavier Levac, Senior Manager of the Unité d’innovations thérapeutiques at the CHUM; Dr. Christine Desbiens, Surgical Oncologist at the CHU de Québec-Université Laval and Maxime Dumais, Development Coordinator at Oncopole.
Source link: Consulat général de France à Québec website